Dr. Thomas Paterson, chief of infectious diseases and PI of the remdesivir clinical trial site locally, discusses the promising early results of the drug in the fight against COVID-19.

Read the full story.

The post KABB: ‘Promising’ treatment for COVID-19 being tested with San Antonio patients appeared first on UT Health San Antonio.